The prognostic significance of @entity1148 in XXXX .

@entity43 @entity1 @entity1148 @entity1423 @entity5 @entity843 @entity54914
@entity43 makes up 25-30% of all cases of @entity5 of the female genital tract. It has the highest mortality rate of any condition in oncological gynaecology. Early diagnosis is associated with a favourable 5-year survival prognosis. Many solid @entity5 have been detected with concomitant @entity1148 . The @entity5 cell-induced @entity1423 is a result of a direct integration of @entity5 cells with blood platelets. The aim of the present paper is an evaluation of platelet count as a prognostic parameter for @entity43 . Between 2000 - 2005, 349 @entity1 with @entity43 (aged 12 - 88-years-old) underwent primary surgical treatment at a clinic. Ninety-seven @entity1 with @entity43 underwent chemotherapy in the Oncology Centre. The control group comprised 252 @entity1 diagnosed with a histopathological lesion of mild intensity, whereas the @entity5 group constituted 97 @entity1 with a histopathologically-diagnosed malignant @entity5 . Thrombocytopaenia was assumed with a platelet count below @entity54914 and thrombocythaemia at 350G/L and higher. @entity1148 often coincides with @entity843 and the cytoreduction decreases platelet count. There is a positive correlation between platelet count and @entity5 grading. @entity1148 was more frequently found in high grade @entity5 . There is also a positive correlation between platelet count and @entity5 stage according the International Federation of Gynaecology and Obstetrics (FIGO). @entity1148 was more frequently found in stage III and IV @entity5 . @entity1 with co-occurring @entity1148 were found to have shorter survival periods and shorter time free from disease. This seems to give grounds for measuring platelet count before the primary surgical intervention, and suggests that the platelet count should be included in the panel of prognostic factors for @entity1 with @entity43 .
